Dyadic to Report 2021 Year-End Financial Results on Tuesday,

JUPITER, Fla., March 15, 2022 -- Dyadic International, Inc. , a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production... | March 15, 2022

Related Keywords

, Dyadic International Inc , Securities Exchange , Dyadic International , Toll Free , Investor Relations , Securities Act , Securities Exchange Act , Nc Stock Exchange , News , Information , Press Release , Arch , 022 , Dyadic , Lobal , Biotechnology , Company , Ocused , N , Urther , Aapplying , End , Deploying , Its , Roprietary , Rotein Dyai Us26745t1016 ,